2-H- 1

본 발명은 선택적 CDK4/6 저해제로서의 치환 2-H-피라졸 유도체를 개시하고 있다. 구체적으로는, 본 발명은 선택적 CDK4/6 저해제로서의 식(I)의 화합물 또는 그 약학적으로 허용되는 염에 관한 것이다. Disclosed is a substituted 2H-pyrazole derivative serving as a selective CDK4/6 inhibitor. Specifically, disclosed is a compound of formula (I) or a pharmaceutically acceptable salt...

Full description

Saved in:
Bibliographic Details
Main Authors XU ZHAOBING, LIN RUIBIN, CHEN SHUHUI, WANG FEI, LIU YINGCHUN, LI JIAN, ZHAO BAOPING, DING CHARLES Z
Format Patent
LanguageEnglish
Korean
Published 15.01.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:본 발명은 선택적 CDK4/6 저해제로서의 치환 2-H-피라졸 유도체를 개시하고 있다. 구체적으로는, 본 발명은 선택적 CDK4/6 저해제로서의 식(I)의 화합물 또는 그 약학적으로 허용되는 염에 관한 것이다. Disclosed is a substituted 2H-pyrazole derivative serving as a selective CDK4/6 inhibitor. Specifically, disclosed is a compound of formula (I) or a pharmaceutically acceptable salt thereof which serves as a selective CDK4/6 inhibitor.
Bibliography:Application Number: KR20177028357